Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Prevalence of 46/1 JAK2 Haplotype in Patients with Budd-Chiari Syndrome with and without JAK2V617F and TET2 Mutations.

Nicholas C Lea, PhD, Lara N Roberts, Raj K Patel, Rachel Westbrook, Michael A Heneghan, Azim M Mohamedali, PhD, Alex E Smith, Atiyeh Abdallah, Nigel Westwood, PhD, CSci, FIBMS, Trisevgeni Kontou, Deborah Yallop, BSc, FRCPath, MB, BS, MRCP, Roopen Arya, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Joop Gaken, PhD, Nigel D Heaton, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath

Blood (2009) 114 (22): 434.

https://doi.org/10.1182/blood.V114.22.434.434

Published: 2009

Journal Articles

Deep Sequencing the Tet2 Gene in 360 Patients with Myeloid Neoplasms Provides a Comprehensive and Quantitative Mutation Map and Reveals Low Level Mutant Clones.

Alexander E Smith, Azim M Mohamedali, PhD, Syed a Mian, Technician, Nicholas C Lea, BSc, PhD, Nigel Westwood, PhD, CSci, FIBMS, Austin G Kulasekararaj, Joop Gaken, PhD, Corinna Strupp, Norbert Gattermann, MD, PhD, Ulrich Germing, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath

Blood (2009) 114 (22): 733.

https://doi.org/10.1182/blood.V114.22.733.733

Published: 2009

Journal Articles

High Resolution Genomic Mapping of Breast Cancer Derived T-MDS/TAML

Azim M Mohamedali, PhD, Natalie Twine, MSc, Joop Gaken, PhD, Nigel Westwood, PhD, CSci, FIBMS, Nicholas Lea, PhD, Rajani Chelliah, MSc, Detlef Haase, MD, PhD, Ghulam J Mufti, FRCP, FRCPath

Blood (2008) 112 (11): 2692.

https://doi.org/10.1182/blood.V112.11.2692.2692

Published: 2008

Journal Articles

MicroRNA Expression Profiling of High and Low Risk MDS

Joop Gaken, PhD, Azim M Mohamedali, PhD, Natalie Twine, Nigel Westwood, PhD, CSCI, FIBMS, Barbara Czepulkowski, Saousan Chehade, Lynn S Quek, Nicholas Lea, PhD, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath

Blood (2008) 112 (11): 3645.

https://doi.org/10.1182/blood.V112.11.3645.3645

Published: 2008

Journal Articles

High Resolution Molecular Analysis of 5q- Syndrome Patients at Diagnosis and Following Lenalidomide Therapy

Azim M Mohamedali, PhD, Nicholas Lea, PhD, Natalie Twine, MSc, Joop Gaken, PhD, Rajani Chelliah, MSc, Nigel Westwood, PhD, CSci, FIBMS, Ghulam J Mufti, FRCP, FRCPath

Blood (2008) 112 (11): 225.

https://doi.org/10.1182/blood.V112.11.225.225

Published: 2008

NARROW

Prevalence of 46/1 JAK2 Haplotype in Patients with Budd-Chiari Syndrome with and without JAK2V617F and TET2 Mutations.

Deep Sequencing the Tet2 Gene in 360 Patients with Myeloid Neoplasms Provides a Comprehensive and Quantitative Mutation Map and Reveals Low Level Mutant Clones.

High Resolution Genomic Mapping of Breast Cancer Derived T-MDS/TAML

MicroRNA Expression Profiling of High and Low Risk MDS

High Resolution Molecular Analysis of 5q- Syndrome Patients at Diagnosis and Following Lenalidomide Therapy

Email alerts

ASH Publications

American Society of Hematology

Prevalence of 46/1 JAK2 Haplotype in Patients with Budd-Chiari Syndrome with and without JAK2V617F and TET2 Mutations.

Deep Sequencing the Tet2 Gene in 360 Patients with Myeloid Neoplasms Provides a Comprehensive and Quantitative Mutation Map and Reveals Low Level Mutant Clones.

High Resolution Genomic Mapping of Breast Cancer Derived T-MDS/TAML

MicroRNA Expression Profiling of High and Low Risk MDS

High Resolution Molecular Analysis of 5q- Syndrome Patients at Diagnosis and Following Lenalidomide Therapy

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only